|
Q3 FY2024
As of Sep 30, 2024
|
Q2 FY2024
As of Jun 30, 2024
|
Q1 FY2024
As of Mar 31, 2024
|
Q4 FY2023
As of Dec 31, 2023
|
Q3 FY2023
As of Sep 30, 2023
|
Q2 FY2023
As of Jun 30, 2023
|
Q1 FY2023
As of Mar 31, 2023
|
Q4 FY2022
As of Dec 31, 2022
|
Q3 FY2022
As of Sep 30, 2022
|
Q2 FY2022
As of Jun 30, 2022
|
Q1 FY2022
As of Mar 31, 2022
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|
| ASSETS | |||||||||||
| Current assets | |||||||||||
| Cash | |||||||||||
| Prepaid expenses | |||||||||||
| Prepaid income taxes | |||||||||||
| Cash and marketable securities held in Trust Account | |||||||||||
| Total Current Assets | |||||||||||
| Cash and marketable securities held in Trust Account | |||||||||||
| Total Assets | |||||||||||
| LIABILITIES AND STOCKHOLDERS' DEFICIT | |||||||||||
| Current liabilities | |||||||||||
| Accounts payable and accrued expenses | |||||||||||
| Due to Non-redeeming Stockholders | |||||||||||
| Promissory note - related party | |||||||||||
| Excise taxes payable | |||||||||||
| Income taxes payable | |||||||||||
| Total Current Liabilities | |||||||||||
| Common stock subject to possible redemption, $0.0001 par value; 1,582,797 shares at $11.22 per share and $10.71 per share redemption value as of September 30, 2024 and December 31, 2023, respectively | |||||||||||
| Stockholders' Deficit | |||||||||||
| Common stock, $0.0001 par value; 50,000,000 shares authorized; 3,336,500 shares issued and outstanding (excluding 1,582,797 shares subject to possible redemption) as of September 30, 2024 and December 31, 2023, respectively | |||||||||||
| Additional paid-in capital | |||||||||||
| Accumulated deficit | |||||||||||
| Total Stockholders' Deficit | |||||||||||
| TOTAL LIABILITIES AND STOCKHOLDERS' DEFICIT |
Loading...
